Understanding Symptoms, Quality of Life in Rumination Syndrome and Development of the MARS Tool (Mayo Adult Rumination Score)

Overview

About this study

The purpose of this study is to:

  1. Assess spectrum of symptoms among patients with rumination syndrome diagnosed at Mayo Clinic (through interviews with previously diagnosed patients);
  2. Assess the quality of life in persons with rumination syndrome (through interviews with previously diagnosed patients); and
  3. Develop a symptom scoring tool which can be used to assess outcomes and response to therapy in this group

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients will be ages 18 to 75 who have previously been diagnoses with Rumination Syndrome.

Exclusion Criteria:

  • Patients who are unable to provide informed consent for the study.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Karthik Ravi, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions